Global Regenerative Medicine Market (2019 Edition)

Date: 1 September 2019

According to the research report published by Azoth Analytics in June 2019, the Regenerative Medicine Market was valued at USD 22814.45 million in the year 2018. Global Regenerative Medicine market is expected to grow rapidly on the back of rising incidences of chronic diseases, rapidly growing medical research facilities, increasing investment by pharmaceutical manufacturers, and growing government initiatives.

The Azoth Analytics research report titled “Global Regenerative Medicine Market (2019 Edition): Opportunities and Forecast (2014-2024)” has analysed and segmented the Market By Type (Cell Therapy, Tissue Therapy, Tissue Engineered), By Application (Orthopaedic and Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology and Oncology, Others). The Global Regenerative Medicine Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (U.S, Canada, Germany, France, Italy, U.K., Japan, China, India, and Brazil) for the historical period of 2014-2018 and the forecast period of 2019-2024.

The status of permanent cure of incurable disease associated with regenerative medicine has led to its growth in the historic period. Further, growing prevalence of burns, autoimmune diseases, oral diseases and chronic diseases have contributed to tremendous growth rate of regenerative medicine. In forecast period, rapidly growing medical infrastructure coupled with briskly increasing government expenditure in regenerative medicine research is anticipated to provide higher momentum to the market growth. In addition, increasing partnerships, collaborative agreements and alliances between biotechnology and healthcare companies is expected to fuel the market growth in forecast period. 

By type, tissue engineered products have dominated the global market in 2018. Their share is anticipated to rise on the back of vast application areas such as wound care, burn treatment, orthopaedics, neurology and urological products. Amongst the regions, North America accounts for the largest regional share in the global regenerative medicine market. Key factors driving the robust growth rate in North America region include presence of enormous patient base, high expenditure on medical infrastructure and growing government initiatives.